SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-005773
Filing Date
2020-02-21
Accepted
2020-02-21 16:38:19
Documents
13
Period of Report
2020-02-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srpt-8k_20200219.htm   iXBRL 8-K 37590
2 EX-10.1 srpt-ex101_7.htm EX-10.1 7822
  Complete submission text file 0001564590-20-005773.txt   178295

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA srpt-20200219.xsd EX-101.SCH 6012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20200219_lab.xml EX-101.LAB 19493
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20200219_pre.xml EX-101.PRE 11663
11 EXTRACTED XBRL INSTANCE DOCUMENT srpt-8k_20200219_htm.xml XML 3558
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 20640620
SIC: 2834 Pharmaceutical Preparations